MAR 01, 2016 05:52 AM PST

FDA Responds to Zika Crisis with New Blood Test

WRITTEN BY: Xuan Pham
New test approved emergency use in Zika detection

Zika is not going away anytime soon, as cases continue to rise in the Americas. The CDC and the FDA are taking note, and in response to this health crisis, have developed and approved use of an emergency diagnostic test for this disease.
 
Called the Zika MAC-ELISA, the test detects immunoglobulin M (IgM) antibodies that are present after exposure to the Zika virus. After infection, the body tries to fight the virus by producing the IgM antibodies, which stays in the blood anywhere from 5 days after infection until 12 weeks when symptoms go away.
 
There are currently no FDA-approved commercial tests for Zika detection, and this new test is issued under the Emergency Use Authorization (EUA). This means that the test will be given under emergency circumstances that impact public health security.
 
The new diagnostic tool will be critical for evaluating high-risk symptomatic patients. However, there are some caveats to the test results. False positive results may arise if the person was infected with a closely related virus, like the dengue, for example. The test could also give false negatives, as the antibodies don’t show up until several days after the infection, and only last around 12 weeks in the blood. So the timing of the test could influence the results dramatically.
 
In the next two weeks, the CDC will be distributing the tests to qualified laboratories. Health officials anticipate that the availability of this new test will improve detection and management of the Zika virus in the US, where there are currently 147 confirmed cases of Zika.
 
The majority of these cases were acquired during travels to Zika-infected areas. Still, Puerto Rico is considered a high-risk area in the US, with CDC Director Tom Frieden confirming that it could have the potential for hundreds of thousands of cases of the virus.
 
Even more troubling, a recent report, published in the medical journal Lancet, found a strong link between the Zika and Guillain-Barre, a rare autoimmune disorder that affects the nervous system. While the incidence of Guillain-Barre is rare on its own, the researchers think Zika may make it less rare.
 
This new link to Guillain-Barre is not yet firmly established. But add this to the microcephaly link, and the new diagnostic test for Zika couldn’t come sooner.
 
  
Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Clinical & Molecular DX
APR 24, 2018
An Atlas of the Human Genome
Scientists from the Hebrew University of Jerusalem want to identify individual genes responsible for specific diseases. This goal inspired their new Nature...
APR 29, 2018
Genetics & Genomics
APR 29, 2018
CRISPR Can Now Edit Genes Outside of the Cell
The CRISPR/Cas9 gene-editing tool was made from an immune defense system used by bacteria. Scientists have found it has many applications....
MAY 14, 2018
Cancer
MAY 14, 2018
What Is Computational Oncology?
Computational Oncology is an emerging field of science and medicine aimed at using mathematical and computer modeling systems to organize tumor marker profiles and hone precision medicine....
JUN 14, 2018
Clinical & Molecular DX
JUN 14, 2018
Automated Blood Drawing Device Coming to Your Doctor's Office
A robot arm could soon be coming to your doctor’s office to take your blood and analyze it for you. From scientists at Rutgers University, this techn...
JUN 21, 2018
Clinical & Molecular DX
JUN 21, 2018
Unique Gene Signature in the Blood Indicates TB Diagnosis
A unique series of genes could tell doctors that a person will develop a tuberculosis (TB) infection months before symptoms are visible. From The Francis C...
JUL 10, 2018
Cardiology
JUL 10, 2018
Going Digital for Heart Disease Detection
A group based out of Scripps has utilized a new, patient-centric, mobile medical device to help diagnosis Atrial Fibrillation....
Loading Comments...